Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

News: Skin Cancer

Clue to Melanoma Drug Resistance

Friday, December 17th, 2010

Patients with metastatic melanoma being treated with the new investigational cancer drug PLX4032 are showing strong responses, with an 80 percent anti-tumor response rate among patients whose tumors are positive for the B-RAF (V600E) gene mutation. However, in all too many cases, patients are developing resistance to the drug and their cancer is beginning to […]

Tennessee Rural Health Worker of Year

Friday, December 17th, 2010

Sheila Bates, L.C.S.W., community outreach manager in Vanderbilt-Ingram Cancer Center’s Office of Patient and Community Education, has been named the Rural Health Worker of the Year by the Rural Health Association of Tennessee. Bates was nominated for her work in the development of the “Cancer Queens! A Cancer Prevention Musical Revue.” The live “edutainment” program, […]

Oncology Clinic Takes Magnet to Heart

Friday, November 19th, 2010

Vanderbilt-Ingram Cancer Center’s Oncology Clinic in Cool Springs makes patient care its priority, and provides a strong example of why the Medical Center is deserving of a second Magnet designation. Though the clinic is 16 miles from the main Vanderbilt University Medical Center campus, the culture of this suburban clinic embodies the VUMC Nursing philosophy […]

New Melanoma Therapy Shows Promise

Friday, November 12th, 2010

A clinical trial of a new experimental therapy for metastatic melanoma being tested at Vanderbilt and several other medical centers has shown positive results, including tumor shrinkage in the majority of patients. The results support previously reported positive data for the drug, known as PLX4032 (RG7204), in a much larger patient population where all responses […]

‘Look Good…Feel Better’ Class Set

Friday, November 12th, 2010

The Vanderbilt Breast Center is inviting cancer patients to a free counseling session designed to help women cope with cancer treatment side-effects such as hair loss and complexion changes. The class is open to patients with all forms of cancer. The “Look Good…Feel Better” class will be held Wednesday, Nov. 17, from 10 a.m. to […]

Writing Workshop for Cancer Survivors

Monday, October 18th, 2010

Cancer survivors interested in exploring the process of creative writing are eligible to attend free Vanderbilt writing workshops this fall. The classes are open to all cancer survivors regardless of where they received their cancer care, and previous writing experience is not required. Participants will have the opportunity to create original material and share their […]

Meeting Explores Cancer’s Impact on Heart

Tuesday, September 28th, 2010

Well-known daytime television actor Anthony Herrera will be the featured guest speaker at this year’s Cardiology & Oncology International Symposium, Thursday, October 7, at the Sheraton Nashville Downtown Hotel. This year’s Cardiology & Oncology International Symposium is designed to help medical professionals identify and screen cancer patients for cardiovascular disease and manage treatment for cancer […]

New Melanoma Drug Creates Excitement

Thursday, September 2nd, 2010

A new drug used to treat advanced melanoma patients with a specific genetic mutation in their tumors demonstrated significant tumor shrinkage in the majority of patients during a clinical trials.

Grant Supports Melanoma Research Efforts

Friday, August 27th, 2010

The Melanoma Research Alliance has awarded a three-year, $2 million grant to a multi-center team of cancer researchers investigating resistance to a new family of BRAF-targeted kinase inhibitor drugs. These targeted therapies are being tested in melanoma patients whose tumors carry a specific genetic mutation known as V600E BRAF. Jeff Sosman, M.D., professor of Medicine […]

VICC Launches Genome-Driven Therapy

Wednesday, August 4th, 2010

Vanderbilt-Ingram Cancer Center (VICC) has launched its new Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast and one of the first in the nation to offer adult cancer patients routine “genotyping” of their tumors at the DNA level. This information will then be used to personalize treatment by matching the appropriate […]

Next Page »« Previous Page